44
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10031 |
EP1-antagonist-1
EP1-antanoist-1,EP1 antagonist 1 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
EP1-antagonist-1 (EP1 antagonist 1) 是 EP1 的拮抗剂,pKi 和 pIC50 分别为 7.54 和 8.5。 | |||
T5841 |
Travoprost
曲伏前列素,Flu-Ipr,Fluprostenol isopropyl ester,AL6221 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Travoprost (Fluprostenol isopropyl ester) 是一种异丙基酯前药,是一种高亲和力的,选择性的 FP 前列腺素全受体激动剂。它能够降低眼压,有潜力应用于青光眼和眼高压。 | |||
T78846 | EP12 | Apoptosis | Apoptosis |
EP12是一种c-Myc抑制剂及c-MycG4稳定剂,能够诱导多发性骨髓瘤细胞的细胞凋亡(apoptosis)及DNA损伤,并通过干扰NF-κB信号通路破坏P65/P50的核转位,从而抑制多发性骨髓瘤的生长。 | |||
T74445 | ZA3-Ep10 | ||
ZA3-Ep10是一种两性离子的脂质,用于合成脂质纳米颗粒,用于体内 RNA 传递和非病毒 CRISPR/Cas 基因编辑。 | |||
TP2197 |
Pep1-TGL
|
Others | Others |
Peptide containing the 'TGL' motif that corresponds to the C-terminus of GluR1 subunit | |||
T11210 |
EP1013
F1013 |
Caspase | Apoptosis; Proteases/Proteasome |
EP1013 is a broad-spectrum selective inhibitor of Caspase used in the study of type 1 diabetes. | |||
T80420 |
TAT-NEP1-40 acetate
|
Apoptosis | Apoptosis |
TAT-NEP1-40 acetate 是促进脑卒中后轴突再生和功能恢复的候选分子。该化合物能够抵御PC12细胞的氧和葡萄糖剥夺(OGD)损伤,并促进神经突生长。它通过抑制神经元凋亡(apoptosis)作用,保护大脑免受缺血再灌注伤害,并能有效传递至大鼠的脑内。 | |||
T80419 |
TAT-NEP1-40 TFA
|
Apoptosis | Apoptosis |
TAT-NEP1-40 TFA 是一种能够穿透血脑屏障的多肽。它能够保护 PC12 细胞抵御缺氧和葡萄糖剥夺 (OGD) 的损害,并促进神经突的生长。此外,TAT-NEP1-40 TFA 可通过减少缺血性脑损伤中的细胞凋亡,以改善神经系统功能。该化合物在中枢神经系统损伤,包括中风后轴突再生及功能恢复的研究中具有潜在应用价值。 | |||
T76273 |
Pep19-2.5
|
||
Pep19-2.5为合成抗毒素肽,能阻断内毒素信号级联。通过抑制跨膜及胞质模式识别受体(PRRs)介导的脂肽(LP)与脂多糖(LPS)的信号通路,Pep19-2.5关键调控与炎症及细胞焦亡(pyroptosis)相关的信号级联。 | |||
TP2196 |
Pep1-AGL
|
Others | Others |
Analog of Pep1-TGL | |||
T80418 |
TAT-NEP1-40
|
Apoptosis | Apoptosis |
TAT-NEP1-40是一种能够穿透血脑屏障的多肽。它能够保护PC12细胞不受缺氧和葡萄糖剥夺(OGD)所致的损伤,同时促进神经突的生长。此外,TAT-NEP1-40通过阻断缺血性脑损伤中的细胞凋亡,对缺血后的神经功能恢复具有积极作用。该化合物适用于中枢神经系统损伤,特别是中风后的轴突再生与功能恢复方面的研究。 | |||
T81517 |
PEP1
|
||
PEP1为具生物活性的肽类化合物。它在低浓度时能够与POPC SLB结合,在高浓度下则会引起POPC SLB的裂解。 | |||
T14148 |
AH 6809
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
AH 6809 是 EP 和 DP 受体的拮抗剂,对小鼠 EP2受体的 Ki 值为 350 nM,对克隆的人类 EP1,EP2,EP3-III 和 DP 受体的 Ki 值分别为 1217、1150、1597 和 1415 nM。 | |||
T21976 |
ONO-8130
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
ONO-8130 是前列腺素 EP1 受体选择性拮抗剂,口服有活力,能够阻断 L6 脊髓中ERK 的磷酸化。它可缓解环磷酰胺致膀胱炎小鼠的膀胱疼痛,可用于研究间质性膀胱炎。 | |||
T11211 |
EP4 receptor antagonist 1
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
EP4 receptor antagonist 1 是一种有效的特异性前列腺素 EP4受体拮抗剂,对人和小鼠 EP4受体的 IC50分别为6.1 nM 和16.2 nM。 EP4 receptor antagonist 1 可用于癌症免疫治疗的研究。 | |||
T63667 |
ONO-8713
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
ONO-8713 是一种选择性的前列腺素E受体亚型EP1拮抗剂,可用于研究圣经系统疾病和代谢相关疾病。 | |||
T14975 |
CJ-42794
CJ-042794 |
Others | Others |
CJ-42794 (CJ-042794)是前列腺素受体 EP4的选择性拮抗剂, 抑制[3H]-PGE2与 EP4受体结合的平均 pKi 为8.5, 对 EP4选择性比 EP1, EP2和 EP3高200多倍。 | |||
T63349 |
Treprostinil diethanolamine
UT-15C |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Treprostinil diethanolamine (UT-15C) 是EP2、DP1和IP 的有效激动剂,对EP2、DP1、IP、EP1、EP4、EP3 和 FPKi 的值分别为 3.6、4.4、32.1、212、826、2505 和 4680 nM。Treprostinil diethanolamine 能够促使 cAMP 的上调,进而维持血管系统内的稳态,并造成人肺动脉的血管扩张。 | |||
T3306 |
PF-04418948
PF 04418948,PF04418948 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
PF-04418948 是一种可口服的,选择性的前列腺素EP2受体拮抗剂,IC50为16 nM。 | |||
T5482 |
TG4-155
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
TG4-155 是一种脑渗透性 EP2 拮抗剂,对 EP2 和 DP1 具有低纳摩尔的拮抗活性。它作用于 EP2 的 KB 为 2.4 nM,比对 DP1 受体的选择性高 14 倍,比对 EP1、EP3、EP4 和 IP 的选择性比高 550-4750 倍。 | |||
T27466 |
GSK-269984B
|
||
GSK-269984B is a novel antagonist of EP1 receptor. | |||
T15421 | GSK-269984A | Others | Others |
GSK-269984A is an antagonist of Prostaglandin E2 Receptor 1 (EP1) (pIC50: 7.9). | |||
T23330 |
SC 19220
|
Others | Others |
EP1 receptor antagonist | |||
T23332 |
SC 51322
|
Others | Others |
SC 51322 is an EP1 prostanoid receptor antagonist. | |||
T15689 |
L-798106
CM9,GW671021 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
L-798106 is a highly selective prostanoid EP3 receptor antagonist (Ki=0.3 nM). It also has micromolar activities at EP4, EP1, and EP2 receptors (Ki: 916 nM, >5000 nM, and >5000 nM at EP4, EP1, and EP2, respectively). | |||
T22125 | ONO-8711 | ||
ONO-8711 是一种有效且选择性的 EP1 受体竞争性拮抗剂(对人和小鼠 EP1 的 Ki 分别为 0.6 和 1.7 nM)。ONO-8711 在结肠癌、乳腺癌和口腔癌小鼠模型中的有效降低肿瘤发生率和多样性。 | |||
T16388 |
Omidenepag isopropyl
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Omidenepag isopropyl is converted to the active product Omidenepag during corneal penetration. Omidenepag isopropyl is a selective EP2 receptor agonist. Omidenepag isopropyl displays only a weak affinity for EP1, EP2, and FP receptors. Omidenepag isopropy | |||
T23404 |
Sulprostone
|
Others | Others |
EP3 and EP1 receptor agonist | |||
T15642 | KAG-308 | Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
KAG-308 is an effective selective and orally active agonist of the EP4 receptor (Ki: 2.57 nM and EC50: 17 nM for human EP4 receptor), more selective over EP1, EP2, EP3, and IP receptor. KAG-308 suppresses colitis and promotes histological mucosal healing, | |||
T37996 |
17-phenyl trinor Prostaglandin E2 ethyl amide
17-phenyl trinor Prostaglandin E2 ethyl amide |
||
17-phenyl trinor PGE2 ethyl amide is derived from 17-phenyl trinor PGE2, a synthetic analog of PGE2 that acts as an agonist of EP1 and EP3 receptors in mice (Ki = 14 and 3.7 nM, respectively) and EP1, EP3, and EP4 in rats (Ki = 25, 4.3, and 54 nM, respectively). 17-phenyl trinor PGE2 causes contraction of guinea pig ileum at a concentration of 11 μM and is 4.4 times more potent than PGE2 as an antifertility agent in hamsters. Modification of the C-1 carboxyl group to an ethyl amide serves to inc... | |||
T69229 |
ONO-8539
|
||
ONO-8539 is a prostanoid EP1 receptor antagonist. | |||
T69602 |
ONO-DI-004
|
||
ONO-DI-004 is a selective EP1 Prostanoid receptor agonist. | |||
T27517 |
GW848687X
GW-848687X,GW 848687X |
||
GW848687X, a potent and selective prostaglandin EP1 receptor antagonist, is used for the treatment of inflammatory pain. | |||
T72513 |
SC 51089 free base
|
||
SC 51089 free base 是一种选择性的前列腺素受体EP1拮抗剂,对EP1,TP,EP3和FP 受体的Ki 值分别为 1.3,11.2,17.5 和 61.1 μM。SC 51089 free base 具有神经保护活性。 | |||
T36080 |
Rivenprost
ONO-4819 |
||
Prostaglandin E2 activates four distinct G protein-coupled receptors, EP1-4. Rivenprost is a potent and selective agonist for the EP4 receptor (Ki = 0.7, 56, 620, and >10,000 nM for EP4, EP3, EP2, and EP1, respectively). It has been used to promote EP4-mediated bone formation, prevent bone loss related to osteoporosis, drive osteoblast differentiation, and stabilize bone implants.[1][2][3][4][5] Rivenprost has also been used to support wound healing.[6] | |||
T37778 |
19(R)-hydroxy Prostaglandin E1
19(R)-hydroxy Prostaglandin E1 |
||
19(R)-hydroxy Prostaglandin E1 是 EP1 和 EP3 受体亚型的激动剂,并对平滑肌表现出收缩活性,也是灵长类动物精液中的主要前列腺素。 | |||
T36212 |
16(S)-Iloprost
|
||
Iloprost is a second generation structural analog of prostacyclin (PGI2) with about ten-fold greater potency than the first generation stable analogs, typified by carbaprostacyclin. Iloprost binds with equal affinity to the recombinant human IP and EP1 receptors with a Ki value of 11 nM. Most preparations of iloprost contain 16(S) and 16(R) stereoisomers. 16(S)-Iloprost potently inhibits platelet aggregation with an IC50 value of 3.5 nM. | |||
T26925 |
Butaprost
Butaprostum,TR-4979,(R)-Butaprost |
||
Butaprost is a chemical compound that functions as a selective agonist for the prostaglandin E receptor (EP2). It exhibits an EC50 of 33 nM and a Ki of 2.4 μM when interacting with the murine EP2 receptor. However, Butaprost demonstrates lower activity against murine EP1, EP3, and EP4 receptors. Furthermore, it effectively attenuates fibrosis by inhibiting the TGF-β/Smad2 signaling pathway [1] [2] [3]. | |||
T21869 |
BW A868C
|
||
BW A868C 是一种乙内酰脲化合物,是 BW245C 结构类似物。BW A868C 是一种选择性强的前列腺素 D2 (PGD2) 竞争性拮抗剂。BW A868C 对其他前列腺素受体 (IP、EP1、EP2、TP 和 FP) 没有影响。 | |||
T29907 |
Alprostadil sodium
PGE1 sodium salt,Prostaglandin E1 sodium |
||
Alprostadil sodium 是一种前列腺素受体配体,对小鼠 EP1、EP2、EP3、EP4和 IP 的 Ki 值分别为 36、10、1.1、2.1 和 33 nM。它诱导血管舒张并抑制血小板聚集,可作为血管扩张剂用于外周血管疾病的研究。 | |||
T38171 | Ro 1138452 hydrochloride | ||
Selective prostacyclin IP receptor antagonist (pKi = 8.3). Exhibits no affinity at other prostanoid receptors (EP1-4, FP and TP) in a radioligand binding assay. Demonstrates analgesic activity in rats. Orally bioavailable. Clark et al (2004) Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists. Bioorg.Med.Chem.Lett. 14 1053 PMID:15013022 |Jones et al (2006) Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel ... | |||
T36211 |
16(R)-Iloprost
|
||
Iloprost is a second generation structural analog of prostacyclin (PGI2) with about ten-fold greater potency than the first generation stable analogs, typified by carbaprostacyclin. Iloprost binds with equal affinity to the recombinant human IP and EP1 receptors with a Ki value of 11 nM. Most preparations of iloprost contain 16(S) and 16(R) stereoisomers. 16(R)-Iloprost inhibits platelet aggregation with an IC50 value of 65 nM. | |||
T23331 |
SC 51089
SC 51089 free base |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
SC 51089 是一种选择性的前列腺素受体 PGE2 拮抗剂,对前列腺素受体亚型具有选择性,具有抗伤害活性,可改善亨廷顿病 R6/1 小鼠模型中的运动缺陷并挽救记忆力下降。 | |||
T16389 | Omidenepag | Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Omidenepag is a pharmacologically active form of Omidenepag Isopropyl and is a selective, non-prostanoid EP2 receptor agonist (EC50: 1.1 nM). Omidenepag displays binding affinities (IC50: 10 nM for h-EP2). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1626 |
Prostaglandin E1
前列地尔,PGE1,列腺素E1,Alprostadil |
Endogenous Metabolite; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism |
Prostaglandin E1 (Alprostadil) 是一种前列腺素受体配体,对小鼠 EP1、EP2、EP3、EP4和 IP 的 Ki 值分别为 36、10、1.1、2.1 和 33 nM。它诱导血管舒张并抑制血小板聚集,可作为血管扩张剂用于外周血管疾病的研究。 |